These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2663589)

  • 1. Methodological problems of randomized clinical trials in the treatment of duodenal ulcer, "gastritis" and Campylobacter pylori infection.
    Poynard T; Pignon JP; Mory B; Naveau S; Chaput JC
    Gastroenterol Clin Biol; 1989; 13(1 Pt 1):112B-115B. PubMed ID: 2663589
    [No Abstract]   [Full Text] [Related]  

  • 2. [Campylobacter pylori and treatment of duodenal ulcer].
    Zelenková J; Toman R; Bielaszewská M; Hanika J; Zeman V
    Vnitr Lek; 1990 Jun; 36(6):573-9. PubMed ID: 2219764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histological gastritis in duodenal ulcer: relationship to Campylobacter pylori and effect of ulcer therapy.
    Dooley CP; McKenna D; Humphreys H; Bourke S; Keane CT; Sweeney E; O'Morain C
    Am J Gastroenterol; 1988 Mar; 83(3):278-82. PubMed ID: 3344730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [What is safe in the treatment of Campylobacter pylori-induced gastritis and Campylobacter pylori-associated peptic ulcer?].
    Menge H
    Internist (Berl); 1988 Nov; 29(11):745-54. PubMed ID: 3069787
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antibacterial treatment of Campylobacter pylori-associated gastritis and peptic ulcer].
    Andreasen JJ; Ringsdal VS
    Ugeskr Laeger; 1989 Apr; 151(17):1030-3. PubMed ID: 2734863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omeprazole, Helicobacter pylori, gastritis, and duodenal ulcer.
    Biasco G; Miglioli M; Barbara L; Corinaldesi R; di Febo G
    Lancet; 1989 Dec; 2(8676):1403. PubMed ID: 2574352
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of bismuth subsalicylate versus cimetidine on Campylobacter pylori, ulcer healing and rate of recurrence].
    Eberhardt R; Kasper G; Dettmer A; Höchter W; Hagena D
    Med Klin (Munich); 1988 May; 83(12):402-5. PubMed ID: 3043160
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antimicrobial drugs in the treatment of stomach and duodenal diseases associated with Campylobacter pylori].
    Perederiĭ VG; Rozhavin MA
    Klin Med (Mosk); 1989 Jan; 67(1):44-8. PubMed ID: 2654463
    [No Abstract]   [Full Text] [Related]  

  • 9. Campylobacter pyloridis is not responsible for duodenal ulcer formation: results of a controlled therapeutic trial.
    Kumar N; Anand BS
    J Assoc Physicians India; 1988 Feb; 36(2):137-9. PubMed ID: 3053613
    [No Abstract]   [Full Text] [Related]  

  • 10. [Campylobacter pylori in patients with chronic gastritis and gastric and duodenal peptic ulcer].
    Kolarski V; Tsenova V; Shopova K; Vasileva E; Petrova D
    Vutr Boles; 1989; 28(2):58-62. PubMed ID: 2763525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Campylobacter pylori gastritis: a pilot study using pirenzepine dihydrochloride (Gastrozepin) and three formulations of colloidal bismuth subcitrate (De-Nol).
    Morris A; Brown P; Ali MR; Lane M; Palmer R
    N Z Med J; 1988 Oct; 101(856 Pt 1):651-4. PubMed ID: 3054641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Campylobacter pyloridis--saprophyte or pathogen?].
    Rösch W
    Leber Magen Darm; 1986 Sep; 16(5):268-75. PubMed ID: 3537597
    [No Abstract]   [Full Text] [Related]  

  • 13. Peptic ulcer: an infectious disease?
    Marshall BJ
    Hosp Pract (Off Ed); 1987 Aug; 22(8):87-96. PubMed ID: 3114282
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experience with the treatment of duodenal ulcer associated with Campylobacter pylori infection by combined use of anti-secretory and antibacterial drugs].
    Grigo'rev PIa; Isakov VA; Iakovenko EP; Agrba VZ; Stepanov AV; Shcherbatykh SI
    Klin Med (Mosk); 1989 Aug; 67(8):52-5. PubMed ID: 2681993
    [No Abstract]   [Full Text] [Related]  

  • 15. Colloidal bismuth subcitrate (DE-NOL) and tinidazole healed duodenal ulceration with a low relapse rate due to elimination of Campylobacter pylori.
    Goodwin CS; Marshall BJ; Blackbourn SJ; Warren JR; Phillips M
    J Chemother; 1989 Jul; 1(4 Suppl):838-9. PubMed ID: 16312662
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of bismuth subsalicylate on the histologic gastritis seen with Campylobacter pylori: a placebo-controlled, randomized study.
    Lanza FL; Skoglund ML; Rack MF; Yardley JH
    Am J Gastroenterol; 1989 Sep; 84(9):1060-4. PubMed ID: 2773899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacteriological and pharmacological basis for the treatment of Campylobacter pylori infection.
    McNulty CA
    Gastroenterol Clin Biol; 1989; 13(1 Pt 1):96B-100B. PubMed ID: 2663605
    [No Abstract]   [Full Text] [Related]  

  • 18. Campylobacter pylori: its role in gastritis and peptic ulcer disease.
    Hornick RB
    Curr Clin Top Infect Dis; 1989; 10():157-73. PubMed ID: 2679692
    [No Abstract]   [Full Text] [Related]  

  • 19. Campylobacter pylori and peptic ulcer therapy.
    Bianchi Porro G; Lazzaroni M
    Gastroenterol Clin Biol; 1989; 13(1 Pt 1):107B-111B. PubMed ID: 2663588
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapy of peptic ulcer and chronic gastritis with bismuth salts].
    Rösch W
    Z Gastroenterol; 1987 Sep; 25 Suppl 4():34-40. PubMed ID: 3687149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.